Willie Sutton Was Right: It’s Time to Turn to the Synovium to Drive Rheumatoid Arthritis Therapy

REFERENCES

1. 1.↵
   1. Ma MH,
   2. Scott IC,
   3. Kingsley GH,
   4. Scott DL

   . Remission in early rheumatoid arthritis. J Rheumatol 2010;37:1444–53.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   Definition of Sutton’s law. [Internet. Accessed October 12, 2016.] Available from www.emedicinehealth.com/script/main/art.asp?articlekey=39253
3. 3.↵
   1. Zeron-Medina J,
   2. Ochoa de Olza M,
   3. Brana I,
   4. Rodon J

   . The personalization of therapy: molecular profiling technologies and their application. Semin Oncol 2015;42:775–87.

   OpenUrl
4. 4.↵
   1. Gregersen PK,
   2. Silver J,
   3. Winchester RJ

   . The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205–13.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Goronzy J,
   2. Weyand CM,
   3. Fathman CG

   . Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis. J Clin Invest 1986;77:1042–9.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bottini N,
   2. Firestein GS

   . Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 2013;15:372.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Frank-Bertoncelj M,
   2. Gay S

   . The epigenome of synovial fibroblasts: an underestimated therapeutic target in rheumatoid arthritis. Arthritis Res Ther 2014;16:117.

   OpenUrl
8. 8.↵
   1. Gerlag DM,
   2. Tak PP

   . How to perform and analyse synovial biopsies. Best Pract Res Clin Rheumatol 2013;27:195–207.

   OpenUrlCrossRef
9. 9.↵
   1. Haringman JJ,
   2. Vinkenoog M,
   3. Gerlag DM,
   4. Smeets TJ,
   5. Zwinderman AH,
   6. Tak PP

   . Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Res Ther 2005;7:R862–7.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Kraan MC,
    2. Reece RJ,
    3. Smeets TJ,
    4. Veale DJ,
    5. Emery P,
    6. Tak PP

    . Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: implications for pathogenesis and evaluation of treatment. Arthritis Rheum 2002;46:2034–8.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Najm A,
    2. Orr C,
    3. Heymann MF,
    4. Bart G,
    5. Veale DJ,
    6. Le Goff B

    . Success rate and utility of ultrasound-guided synovial biopsies in clinical practice. J Rheumatol 2016;43:2113–9.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Humby F,
    2. Kelly S,
    3. Bugatti S,
    4. Manzo A,
    5. Filer A,
    6. Mahto A,
    7. et al.

    Evaluation of minimally invasive, ultrasound-guided synovial biopsy techniques by the OMERACT filter—determining validation requirements. J Rheumatol 2016;43:208–13.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Humby F,
    2. Kelly S,
    3. Hands R,
    4. Rocher V,
    5. DiCicco M,
    6. Ng N,
    7. et al.

    Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials. Arthritis Rheumatol 2015;67:2601–10.

    OpenUrl
14. 14.↵
    1. Kelly S,
    2. Humby F,
    3. Filer A,
    4. Ng N,
    5. Di Cicco M,
    6. Hands RE,
    7. et al.

    Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann Rheum Dis 2015;74:611–7.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Lazarou I,
    2. D’Agostino MA,
    3. Naredo E,
    4. Humby F,
    5. Filer A,
    6. Kelly SG

    . Ultrasound-guided synovial biopsy: a systematic review according to the OMERACT filter and recommendations for minimal reporting standards in clinical studies. Rheumatology 2015;54:1867–75.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Cuppen BV,
    2. Welsing PM,
    3. Sprengers JJ,
    4. Bijlsma JW,
    5. Marijnissen AC,
    6. van Laar JM,
    7. et al.

    Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology 2016;55:826–39.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Wijbrandts CA,
    2. Vergunst CE,
    3. Haringman JJ,
    4. Gerlag DM,
    5. Smeets TJ,
    6. Tak PP

    . Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum 2007;56:3869–71.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. de Hair MJ,
    2. Harty LC,
    3. Gerlag DM,
    4. Pitzalis C,
    5. Veale DJ,
    6. Tak PP

    . Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis. J Rheumatol 2011;38:2068–72.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. van de Sande MG,
    2. Baeten DL

    . Immunopathology of synovitis: from histology to molecular pathways. Rheumatology 2016;55:599–606.

    OpenUrlAbstract/FREE Full Text